FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga

Saved in:

Bibliographic Details
Published in:	Nucleic acid therapeutics Vol. 27; no. 1; pp. 1 - 3
Main Authors:	Aartsma-Rus, Annemieke, Krieg, Arthur M.
Format:	Journal Article
Language:	English
Published:	Los Angeles, CA Mary Ann Liebert, Inc 01.02.2017 SAGE Publications
Subjects:	Adolescent Child Clinical Trials as Topic Dose-Response Relationship, Drug Drug Approval Dystrophin - genetics Exons Humans Issues in Development Morpholinos - therapeutic use Muscular Dystrophy, Duchenne - drug therapy Muscular Dystrophy, Duchenne - economics Oligonucleotides - therapeutic use Time Factors Treatment Outcome United States United States Food and Drug Administration Walk Test Young Adult splicing modulation therapy regulatory oligonucleotide
ISSN:	2159-3337, 2159-3345, 2159-3345
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!